Emerging Clinical Data and Techniques: A Growing Body of Evidence for CAVT & PE

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Boston Scientific Corporation; Medtronic; Abbott; Penumbra; Cordis Corporation, a Johnson & Johnson company</li><li>Equity/Stock(s)/Options - Thrombolex; Imperative Vascular; Innova Vascular; Summa Therapeutics; aidoc; votis</li></ul>